Medicare Extension of Drugs to Seniors (MEDS) Act of 2001
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Outlines provisions for substantial reductions in the price of prescription drugs for Medicare beneficiaries.
Amends the Federal Food, Drug, and Cosmetic Act, as amended by the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2001, with respect to the importation of certain prescription drugs, to revise testing requirements (granting the Secretary certain waiver discretion) and add approved labeling requirements.
Requires the recipient of a patent to make a reasonable pricing agreement with the Secretary (or the Secretary to waive such an agreement in the public interest) if any Federal agency or any non-profit entity: (1) undertakes federally funded health care research and development; and (2) is to convey or provide a patent or other exclusive right to use such research and development for a drug or other health care technology.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 1512: Medicare Extension of Drugs to Seniors (MEDS) Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-1512/
"H.R. 1512: Medicare Extension of Drugs to Seniors (MEDS) Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-1512/.
H.R. 1512, 107th Cong. (2026), https://openamerica.io/bill/107-HR-1512/.
[H.R. 1512: Medicare Extension of Drugs to Seniors (MEDS) Act of 2001](https://openamerica.io/bill/107-HR-1512/)